9th Annual Biomarkers Congress
4th Vaccine and ISV Annual Global Congress
Vienna, Austria

mm, mm
http://www.vaccinecongress.com
   Deadlines
   ---------

     *  Abstract Deadline:
       18th June 2010

   Now in its fourth year, the annual Vaccine Congress has become the
   forum for the exchange of ideas to accelerate the rate at which
   vaccines can come to benefit the populations that need them.

   The key objectives of the congress are:

     *  To provide a progressive state-of-the-art report for scientists,
       governmental authorities and healthcare workers with dedicated
       sessions for each group

     *  To accelerate progress in the development of vaccines

     *  To encourage a prophylactic approach to healthcare

Schedule of Presentations:

Sunday, October 3, 2010
09:00:00 Conference Registration
11:00:00 Opening Session & Plenary Session 1 Ray Spier
11:05:00 Opening remarks Shan Lu
11:30:00 Infectious disease vaccines in the light of unmet medical need, new technologies and challenges Alexander Von Gabain
12:00:00 Expanding immunization against human Salmonella infections: vaccines to prevent invasive non-typhoidal Salmonella infections emerging in sub-Saharan Africa and Salmonella Paratyphi A in Asia Myron M. Levine
12:30:00 Lunch + Satellite Symposium (GSK)
14:00:00 Plenary Session 2
14:05:00 Control major infectious diseases in developing countries
14:10:00 HIV vaccine phase III trial Mark DeSouza
14:30:00 The RTS,S malaria vaccine candidate: From concept to pivotal Phase 3 testing Joe Cohen
15:00:00 Clinical trials of antigen-antibody complex-based therapeutic vaccine for viral hepatitis B: the present and the future Yumei Wen
15:15:00 Oral presentations selected from abstract submissions (2x)
15:30:00 Refreshment Break
16:00:00 Plenary Session 3: Gene and subunit vaccines
16:30:00 Potent as well as protective immune responses induced by highly engineered DNA vaccines delivered by Cellectra™ EP in Nonhuman Primates and Humans D B Weiner
17:00:00 Development of universal influenza virus vaccines Adolfo Garcia-Sastre
17:30:00 Recombinant envelope protein domain III as a dengue vaccine candidate? Alan D.T. Barrett
17:45:00 Oral presentations selected from abstract submissions (4x)
18:00:00 Poster/Exhibition Session 1 and Welcome Reception
Monday, October 4, 2010
08:30:00 Plenary Session 4: Vaccine Pipelines
09:00:00 The development of Prevenar 13: A second-generation vccine for the prevention of pneumococcal disease Emilio Emini
09:45:00 Creating innovative vaccines for the 21st century Christian Mandl
10:00:00 Utilization of traditional and new technologies for novel vaccine development John W. Shiver
10:15:00 Oral presentations selected from abstract submissions (4x)
10:30:00 Refreshment Break
10:55:00 Parallel Breakout Sessions 1 & 2
11:00:00 Breakout Session 1: JSV Sponsored Session
11:00:00 Breakout Session 2: Vaccines' efficacy and safety
11:30:00 MucoNanogel antigen delivery system for adjuvant-free nasal vaccines | Session 1 Hiroshi Kyono
11:30:00 Speaker to be announced | Session 2
12:00:00 Post- and pre-exposure vaccination with a highly-attenuated smallpox vaccine, LC16m8, and efficacy in protection of nonhuman primates from lethal monkeypox | Session 1 Masayuki Saijo
12:00:00 Post licensure vaccine safety and effectiveness: contribution of statistical approaches | Session 2 Nick Andrews
12:15:00 Oral presentations selected from abstract submissions (4x) | Session 1
12:15:00 Oral presentations selected from abstract submissions (4x) | Session 2
12:30:00 Lunch + Satellite Symposium
14:00:00 Poster Session 2
14:05:00 ISV Business Meeting Ray Spier
15:45:00 Plenary Session 5: Policy and epidemiology
16:15:00 Speaker to be announced
16:40:00 PATH: Vaccines for the developing world - Novel vaccines: design & development Rick Bright
17:20:00 Oral presentations selected from abstract submissions (6x)
19:00:00 Congress Dinner
Tuesday, October 5, 2010
08:30:00 Plenary Session 6: Antiinfective antibodies
09:00:00 Invited speaker to be announced Invited speaker to be announced
10:00:00 Oral presentations selected from abstract submissions (6x)
10:30:00 Refreshment Break
10:55:00 Parallel Breakout Sessions 3 & 4
11:00:00 Breakout Session 3: Cancer vaccines and other novel vaccines
11:00:00 Breakout Session 4: Veterinary Vaccines
11:05:00 Development of parasite vaccines: an update | Session 4 TPM Schetters
11:05:00 Cancer vaccines: a tractable solution for an intractable problem | Session 3 Olivera J. Finn
11:30:00 Preclinical evaluation of influenza vaccines based on replication-deficient poxvirus vector MVA | Session 3 Guus Rimmelzwaan
11:30:00 Speaker to be announced | Session 4
12:00:00 Oral presentations selected from abstract submissions (4x) | Session 4
12:00:00 Oral presentations selected from abstract submissions (4x) | Session 3
12:30:00 Lunch + Satellite Symposium
14:00:00 Plenary Session 7: Vaccines in the future
14:05:00 Reflections on the life and times of Edward Jenner Greg Poland
14:30:00 Speaker to be announced
15:00:00 Development of Vero-cell derived pandemic and seasonal influenza vaccines Noel Barrett
15:30:00 Speaker to be announced
16:00:00 Closing Summary Shan Lu, Ray Spier
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.